PTPRC and neoplasm: In the present study, we found that the tumor-infiltrating monocytes (CD45+CD11b+CD115+Ly6G-) could be classified into two subpopulations, Ly6C+ and Ly6C- monocytes, with combination immunotherapy treated tumors showing higher percentage of Ly6C+ (Figure 5A).